As PTEN loss was demonstrated to be associated with a high Gleason score, PCa pathological stages and promoted the progression of lymph node metastasis, PTEN may serve as a potential early prognostic marker in prostate cancers [215,216,217,218,219]. This evidence concerns the gene PTEN and prostate carcinoma.